Aerie Pharmaceuticals reported $-39614000 in Equity Capital and Reserves for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Adamas Pharmaceuticals ADMS:US -4033000 9.97M
Aerie Pharmaceuticals AERI:US $ -39.61M 29.25M
Amarin AMRN:US $ 645.32M 10.71M
Antares Pharma ATRS:US $ 132.03M 5.8M
Bluebird Bio BLUE:US $ 984.56M 215.77M
Cara Therapeutics CARA:US $ 203.47M 26.99M
Coherus Biosciences CHRS:US $ 156.22M 28.55M
Endo International Ordinary Shares ENDP:US $ -617.04M 18.07M
Flexion Therapeutics FLXN:US $ -56171000 17.3M
Gw Pharmaceuticals GWPH:US $ 736.37M 4.72M
Horizon Pharma HZNP:US $ 4073.64M 218.87M
Insmed INSM:US $ 531.05M 329.42M
JAZZ PHA JAZZ:US $ 4131.49M 333.8M
Mirati Therapeutics MRTX:US $ 1128.92M 130.49M
Novartis NOVN:VX SF 54042M 3519M
Pacira Pharmaceuticals PCRX:US $ 687.17M 36.35M
Regeneron Pharmaceuticals REGN:US $ 15127.3M 3150.3M
Revance Therapeutics RVNC:US $ 186.24M 58.01M
Supernus Pharmaceuticals SUPN:US $ 785.58M 31.14M
Teva Pharmaceutical Industries TEVA:US $ 10324M 324M
Valeant Pharmaceuticals VRX:CN $ -687M 490M
Zoetis ZTS:US $ 4350M 261M
Zogenix ZGNX:US $ 272.86M 48.42M